Private DALK transplant for keratoconus — UK 2026 corneal pathway guide

What is DALK and why does the lamellar approach matter?

The cornea is a five-layered structure: the epithelium (a regenerating skin), Bowman’s layer (a thin collagen sheet), the stroma (the thick collagen and keratocyte body of the cornea), Descemet’s membrane (a basement membrane), and the endothelium (a single layer of pump cells that maintain corneal transparency by actively dehydrating the stroma). In keratoconus, the disease progressively thins and deforms the stroma; the endothelium is histologically and functionally normal. In post-infective scarring, post-traumatic scarring and most stromal dystrophies, the same principle holds — the diseased layers are anterior to Descemet’s membrane, and the endothelium is intact.

Full-thickness penetrating keratoplasty (PK), the traditional corneal transplant, replaces all five layers. This is appropriate when the recipient endothelium is also diseased (Fuchs’ dystrophy in late stages, prior endothelial graft failure, severe endothelial trauma). It is unnecessary — and arguably harmful — when the recipient endothelium is healthy, because the donor endothelium then becomes the target of lifelong endothelial rejection risk, the principal cause of graft failure at 5-15 years post-PK.

DALK replaces only the epithelium, Bowman’s layer and the stroma to Descemet’s membrane. The recipient’s own healthy Descemet-endothelial complex is left in place. Because the endothelium is the immunologically active layer of the cornea, retaining the host endothelium essentially eliminates the risk of endothelial rejection (the immunologic insult that drives most graft failure). Stromal rejection can still occur but is more easily reversed with topical steroid and rarely causes irreversible graft failure.

The technical challenge of DALK is the dissection: separating the diseased stroma from Descemet’s membrane without microperforating Descemet’s membrane (which would force conversion to PK). The modern standard technique, described by Anwar in 2002, uses an intracameral air injection (the ‘big bubble’) to cleave the stroma from Descemet’s membrane in a single controlled plane. In experienced hands, big-bubble success rates exceed 85-90%, with conversion to PK in the remaining 10-15% of cases. A femtosecond laser can be used to perform the recipient trephination and initial lamellar cut (femto-DALK), adding precision but not avoiding the conceptual challenge of the deep dissection itself.

UK 2026 DALK transplant pricing, in detail

Below is a typical UK 2026 private fee structure for DALK at a CQC-registered London corneal centre. DALK is a complex tertiary corneal operation; pricing reflects the donor tissue cost, the long surgical time and the substantial postoperative suture-care commitment.

If you are considering alternatives for keratoconus, see private corneal cross-linking (CXL), private intracorneal ring segments (Intacs / Keraring), private CAIRS corneal allograft ring segments and private penetrating keratoplasty (PK). For lamellar endothelial graft surgery, see private ultra-thin DSAEK and private DMEK. Underlying disease: keratoconus.

What a quality UK DALK package should include

When you read a private quote for DALK, check it explicitly covers each of the following. DALK is a tertiary procedure and unbundled fees are a meaningful proportion of the total cost.

• Consultant corneal surgeon — GMC-registered consultant ophthalmologist with a completed 12-month minimum corneal fellowship, a substantive NHS corneal post and documented DALK case volume of at least 50 cases.
• Genuine NHSBT or BSI 4 donor cornea — Donor tissue from NHS Blood and Transplant or an equivalent BSI 4 eye bank with full serology, endothelial cell count and traceability documentation; the donor identifier and tissue lot are recorded in your notes.
• Same-week consultation and planning — Advanced keratoconus eyes can deteriorate quickly; expect a consultation, Pentacam and donor-tissue listing within 7-14 days.
• Pentacam Scheimpflug tomography — Pre-operative anterior and posterior corneal elevation, full pachymetry mapping and keratoconus staging; required for surgical planning.
• Specular microscopy of recipient endothelium — Confirms recipient endothelial cell count is adequate; if not, DALK is inappropriate and PK or endothelial grafting is needed.
• Anterior segment OCT (intraoperative or pre-operative) — Helpful for assessing residual stromal bed thickness if a non-big-bubble manual layered dissection is performed.
• CQC-registered ophthalmic operating theatre — Inspected and rated ‘Good’ or ‘Outstanding’ on Safe and Effective domains; capable of accommodating an emergency conversion to PK with full anterior segment kit on standby.
• Consultant anaesthetist if general anaesthetic used — Or experienced sub-Tenon’s block by the surgical team; preserved cardiovascular monitoring throughout.
• Donor cornea preparation in theatre by the surgical team — Punch-cutting of the donor button under sterile conditions by the consultant; not a delegated technician task.
• Postoperative drop regime and written taper schedule — Topical antibiotic for 1 week, prolonged topical steroid taper over 12-18 months, written schedule provided.
• Suture-care schedule across 12-18 months — Monthly slit-lamp reviews in the first 6 months; suture-tightness and graft topography assessment from month 4; selective suture removal from month 6.
• Topography-guided selective suture removal — Pentacam or anterior segment OCT-guided suture removal to manage post-DALK astigmatism.
• RGP contact lens fitting pathway — Many post-DALK patients need rigid gas-permeable contact lens fitting for best-corrected vision; the surgical centre should have an in-house or partnered optometrist.

Evidence base — what the DALK literature shows

DALK is supported by two decades of high-quality cohort and comparative evidence demonstrating equivalent or superior visual outcomes to PK with materially better long-term graft survival.

• Anwar M, Teichmann KD (2002) — Original description of the big-bubble technique for DALK in the British Journal of Ophthalmology; foundational paper for modern DALK practice.
• Reinhart WJ et al. (2011, Ophthalmology) — AAO Ophthalmic Technology Assessment of DALK versus PK in keratoconus and other anterior stromal disease.
• Cochrane systematic review on DALK vs PK in keratoconus — Meta-analysis demonstrating equivalent best-corrected visual acuity outcomes with materially lower endothelial cell loss and lower long-term graft failure rates after DALK.
• UK Transplant Registry corneal data — NHS Blood and Transplant corneal transplant registry data on graft survival, rejection and re-operation rates by graft type.
• Royal College of Ophthalmologists corneal guideline — RCOphth standards on keratoplasty, donor tissue handling and postoperative care.
• EuCornea practice guidance — European Society of Cornea and Ocular Surface Disease Specialists guidance on DALK technique selection and outcome reporting.
• Femto-DALK comparator series — Cohort and randomised comparator data on femtosecond laser-assisted versus manual DALK trephination.
• Sarnicola E et al. on DALK technique variants — Comprehensive series of viscoelastic-assisted and big-bubble DALK variants with conversion rates.
• Long-term DALK survival data (10-year) — Multiple long-term cohorts showing >90% 10-year graft survival in DALK compared to 60-75% for PK in keratoconus.
• Corneal cross-linking comparator trials — CXL studies (Wollensak, Caporossi, Raiskup) demonstrating that early keratoconus does not need transplant; CXL can halt progression.
• BSI 4 eye-banking standards — British Standards Institute BS EN ISO 17665 and tissue-banking standards governing donor cornea preparation in the UK.

DALK versus the other corneal transplant and keratoconus options

Keratoconus management is now a stepped pathway rather than a binary choice. The right intervention depends on disease stage, corneal thickness, scarring, visual potential and patient lifestyle.

• Corneal cross-linking (CXL) — First-line for progressive keratoconus in eyes with thickness >400 microns; halts progression by ~85-95% with minimal disruption. Does not improve existing topography or vision; reserved for earlier disease, before the stroma is too thin or scarred for transplant to be deferred.
• Intracorneal ring segments (Intacs, Keraring, Ferrara) — Polymethylmethacrylate ring segments implanted in mid-stromal channels (manual or femtosecond) to flatten the cone and improve topography. Suitable when CXL has stabilised the cone but BCVA is poor with spectacles or contact lenses, and the cornea is thick enough.
• CAIRS (Corneal Allograft Intra-stromal Ring Segments) — Donor corneal tissue cut into ring segments and implanted in stromal channels; conceptually similar to PMMA rings but uses donor tissue, avoiding the long-term inflammation and extrusion risks of synthetic implants.
• Penetrating keratoplasty (PK) — Full-thickness corneal transplant; reserved for eyes with diseased recipient endothelium, full-thickness scarring, or after failed DALK. Faster surgery and faster visual recovery than DALK but lifelong endothelial rejection risk and inferior long-term graft survival.
• DSAEK (Descemet’s stripping automated endothelial keratoplasty) — Posterior lamellar graft of donor endothelium plus a thin layer of posterior stroma; the opposite anatomical operation to DALK. Used for endothelial disease (Fuchs’ dystrophy, bullous keratopathy), not stromal disease.
• DMEK (Descemet’s membrane endothelial keratoplasty) — Even thinner posterior endothelial graft than DSAEK; the gold standard for endothelial disease. Like DSAEK, not used for stromal disease.
• Scleral RGP contact lenses — Large-diameter rigid gas-permeable contact lenses vault over the corneal apex with a fluid reservoir; can give excellent BCVA in established keratoconus and may defer the need for transplant indefinitely if the cornea is not scarred and the patient tolerates the lens.
• Femto-DALK (femtosecond laser-assisted) — Femtosecond laser performs the recipient trephination and the initial lamellar cut; the deep dissection is still manual or big-bubble. Adds precision and predictability but does not eliminate the technical challenge of separating Descemet’s membrane.
• Observation alone — Stable mild keratoconus with good spectacle or soft-lens BCVA does not need intervention; many patients live their entire lives without progression once they reach their late 30s when keratoconus typically stabilises.

Who is private DALK the right choice for?

DALK is at its best for patients with advanced anterior stromal corneal disease, healthy recipient endothelium and a long expected visual lifetime where a 30-year graft horizon matters.

• Advanced keratoconus with poor BCVA in spectacles and contact lenses — Corneal scarring, contact-lens intolerance or progression past the corrective limit of scleral RGP lenses is the classic DALK indication.
• Post-hydrops keratoconus — Acute corneal hydrops (rupture of Descemet’s membrane with stromal oedema) leaves stromal scarring that does not respond to lenses; once the acute episode has settled and the cornea has remodeled, DALK is the standard surgical option.
• Stromal corneal scarring from infection or trauma — Healed bacterial keratitis, herpes simplex stromal scar, post-traumatic stromal opacity — provided the endothelium is intact.
• Stromal corneal dystrophies — Granular, lattice and macular stromal dystrophies that have progressed to visually significant central opacity.
• Failed previous corneal cross-linking or ring segments — When earlier interventions have stabilised but not corrected the cone, and visual function remains inadequate, DALK is the next step.
• Healthy recipient endothelium on specular microscopy — Endothelial cell count of 1,500-2,000 cells per square millimetre or higher; below this, PK or endothelial grafting is more appropriate.
• Younger patients (under 40) with progressive keratoconus — Long expected visual lifetime makes the longer-lived DALK graft particularly valuable; rejection-driven failure becomes the dominant lifelong issue in PK eyes.
• Patients prioritising long-term graft survival over short-term recovery speed — DALK takes longer in theatre and has a slower visual recovery than PK but has materially better 10-year and 20-year graft survival.
• Patients on anticoagulation — DALK can be performed safely on warfarin, DOACs and dual antiplatelet therapy without medication interruption.
• Patients who can commit to the 12-18 month suture-care schedule — DALK postoperative care is intensive; willingness and ability to attend monthly reviews and topography-guided suture removal is a candidacy requirement.
• Patients who have failed contact lens trial — Scleral RGP lens trial under a specialist contact lens optometrist should generally precede transplant in keratoconus; surgical pathway opens after lens trial demonstrates inadequate BCVA or intolerance.
• Patients keen to avoid lifelong endothelial rejection risk — The signature advantage of DALK over PK is essentially eliminating endothelial rejection, which is the principal cause of late graft failure.

NHS versus private DALK transplant

DALK is available on the NHS at tertiary corneal centres throughout the UK, including Moorfields Eye Hospital, the Manchester Royal Eye Hospital, the Bristol Eye Hospital and other regional corneal services. NHS corneal tissue allocation is centralised through NHS Blood and Transplant, which holds the UK national eye bank inventory and allocates donor tissue based on clinical urgency. NHS DALK surgery is excellent and is the same operation performed in private practice, often by the same consultant surgeons.

The challenge with NHS DALK is wait times. Elective DALK referrals through the NHS DM01 pathway commonly wait 12-24 months for surgical date in 2026, longer in some integrated care boards under post-pandemic backlog pressures. For stable keratoconus this is usually clinically acceptable — the disease has typically been progressing slowly for years — but it is frustrating for patients whose contact lens tolerance is dropping, and it can be clinically problematic for patients with progressing scarring or post-hydrops eyes losing useful vision month by month.

Many keratoconus patients use a hybrid pathway: NHS for diagnosis and contact-lens trial under specialist optometry, and private for the DALK surgery itself once surgical decision is made. The receiving consultant for postoperative monitoring can usually be the same surgeon (a private patient does not need to be transferred mid-care to NHS for suture removal), and several leading private corneal surgeons work part-NHS, part-private and operate seamlessly across both settings.

Private medical insurance and DALK transplant

Bupa, AXA Health, Aviva, Vitality and WPA all cover DALK under their standard corneal surgical pathways subject to your specific policy benefits, excess and pre-authorisation requirements. Keratoconus is generally treated as a chronic condition for insurance purposes; check whether your policy covers chronic-condition surgical intervention and what limits apply to the 12-18 month postoperative suture-care period. CCSD procedure codes for DALK and femto-DALK are established, and the donor cornea is typically billed as an itemised consumable on top of the procedure code. Pre-authorisation requires the consultant’s assessment letter, Pentacam topography, specular microscopy, contact-lens trial record (insurers usually require demonstration that contact lenses have been trialled and failed before authorising transplant) and the planned procedure code; the clinic’s administrative team handles the submission. Premium femto-DALK upgrades are often self-funded on top of the insured DALK portion. The long suture-care course beyond 12 weeks may not be covered by acute-condition policies; clarify in writing before surgery.

Risks of DALK transplant surgery

DALK is intraocular surgery on a sight-critical structure with a 12-18 month postoperative care commitment. The risks below are individually manageable but cumulative across a long postoperative course.

• Intraoperative conversion to PK — 10-15% of big-bubble DALK cases convert to PK intraoperatively due to Descemet’s membrane microperforation. Conversion is not a complication per se but changes the operation to a full-thickness graft with PK-style postoperative considerations.
• Double anterior chamber — Residual air between donor graft and recipient Descemet’s membrane causing displacement; usually resolves with intracameral air re-injection in the first few days.
• Stromal graft rejection — Approximately 5-15% of DALK eyes experience a stromal rejection episode over the graft lifetime; typically responsive to topical steroid intensification with no long-term consequence. Endothelial rejection is essentially eliminated in DALK.
• Graft failure (early) — Primary graft failure from intraoperative trauma or donor tissue issue; rare with NHSBT-quality tissue and experienced surgical hands.
• Graft failure (late) — Late graft failure rates are materially lower than PK; the main residual cause is severe stromal rejection or recurrent disease (e.g. recurrent stromal dystrophy).
• Endophthalmitis — <1 in 1,000 risk; presents at days 3-7 with pain, vision loss and hypopyon; managed with same-day vitreoretinal tap-and-inject.
• Suture-related complications — Loose, broken or buried sutures occur across the 12-18 month suture course; need careful slit-lamp follow-up and selective removal to avoid microbial keratitis.
• Post-graft astigmatism — Even with topography-guided selective suture removal, residual post-DALK astigmatism is common and typically requires rigid gas-permeable contact lens or post-suture refractive surgery for best-corrected vision.
• Wound dehiscence with trauma — The corneal trephination scar is structurally weaker than virgin cornea for many years; significant blunt trauma can dehisce the wound. Protective eyewear is advised for high-risk activities.
• Microbial keratitis (long-term) — Sutures and a partially compromised epithelium predispose to bacterial or fungal keratitis; prompt review for any red eye, pain, photophobia or vision drop is essential throughout the postoperative course.
• Glaucoma (steroid-induced) — The long topical steroid taper carries a steroid-response IOP rise in approximately 15-25% of eyes; managed with topical glaucoma medication and tapering the steroid potency.
• Cataract progression — Long-term topical steroid use accelerates nuclear sclerosis; many post-DALK patients eventually need cataract surgery, often a complex operation in a post-grafted eye.
• Recurrence of original disease — Stromal dystrophies (granular, lattice, macular) can recur in the donor graft over 5-15 years; keratoconus does not recur in the graft but can progress in the unoperated peripheral host stroma.
• Need for re-operation — Approximately 10-20% of DALK eyes need at least one additional procedure over the graft lifetime — topography-guided refractive surgery, suture revision, ICRS, repeat keratoplasty or cataract surgery.

Recovery after DALK transplant surgery

DALK recovery has two distinct phases: a short surgical recovery (1-2 weeks) and a long visual-rehabilitation phase (12-24 months). Understanding both is essential to a realistic decision about the operation. You arrive at the day-case unit a few hours before surgery, are taken to theatre for the 90-150 minute procedure under general or sub-Tenon’s anaesthesia, recover briefly and are discharged the same day with the eye protected by a shield.

In the first 1-2 weeks, vision is misty and the eye is mildly uncomfortable as the corneal surface heals over the suture knots. You wear an eye shield at night for 6 weeks to prevent inadvertent rubbing and start a tapering topical steroid drop (typically dexamethasone or prednisolone, four times daily tapering over 12-18 months) plus a topical antibiotic for the first 1-2 weeks. You attend day 1, week 1 and week 4 reviews for slit-lamp examination of the graft-host interface, IOP check and suture inspection.

From week 2 to month 3, vision steadily improves but is heavily dependent on the suture configuration. Most patients see well enough to read large print and watch television from week 3-4 and improve gradually thereafter. Astigmatism is high in the early postoperative period because the sutures distort the graft surface; selective suture removal (typically from month 6 onwards) is what unlocks the underlying graft potential.

From month 4 to month 12, the surgical priority is topography-guided suture management. Pentacam or anterior segment OCT topography is used to identify the steepest meridia of post-graft astigmatism; the sutures running through these zones are selectively removed to allow the graft to flatten symmetrically. This is the most skill-dependent part of post-DALK care — suture removal too early causes graft distortion, too late causes irreversible high astigmatism. Most patients have all sutures out by month 12-18.

From month 12-24, best-corrected vision is achieved. Roughly two-thirds of patients achieve 6/12 (driving standard) or better with spectacle correction; the remainder require rigid gas-permeable contact lens fitting to reach best-corrected vision. The graft itself is in its long stable phase, with annual review for IOP, endothelial cell count and any signs of stromal rejection. The 24/7 emergency contact pathway remains active throughout for any red eye, pain, photophobia or vision drop, which can signal microbial keratitis or rejection at any point in the graft lifetime.

How to choose a London clinic for DALK transplant

DALK is one of the most technique-dependent operations in ophthalmology. Surgeon experience, donor-tissue handling and the postoperative suture-care infrastructure all materially affect outcome.

• Consultant with a corneal fellowship and substantive corneal post — GMC-registered consultant ophthalmologist with a 12-month minimum corneal subspecialty fellowship and an NHS corneal post at Moorfields, the Western Eye Hospital, King’s, the Royal Free or comparable corneal centre.
• Documented DALK case volume — Ask how many DALK procedures the surgeon has performed; 50+ is a reasonable threshold for the principal big-bubble learning curve. UK Transplant Registry data is one source of validation.
• Big-bubble technique competency — Big-bubble success rate of 80-90% is the modern benchmark; lower success rates suggest more conversions to PK.
• Femto-DALK capability if needed — Some clinics offer femtosecond laser-assisted DALK; useful in selected cases but not essential for good outcomes.
• CQC inspection rating — Care Quality Commission report on the day-case unit; you want ‘Good’ or ‘Outstanding’ on Safe and Effective domains.
• NHSBT or equivalent BSI 4 donor tissue — Donor cornea source should be NHS Blood and Transplant or an equivalent BSI 4-accredited eye bank with full serology, traceability and endothelial cell count documentation.
• Pentacam Scheimpflug tomography on site — Essential for surgical planning and postoperative topography-guided suture removal; clinics without Pentacam capability are unlikely to manage post-DALK astigmatism optimally.
• In-house or partnered specialist contact lens optometrist — Many post-DALK eyes need rigid gas-permeable contact lens fitting for best-corrected vision; the centre should have a specialist optometrist on the pathway.
• Suture-care infrastructure across 12-18 months — DALK postoperative care extends for 12-18 months; the centre must have appointment capacity for monthly reviews and topography-guided selective suture removal over that period.
• 24/7 emergency contact for rejection and infection — Written telephone pathway to a corneal on-call surgeon within hours of new symptoms throughout the graft lifetime, not just the first 12 weeks.
• Written long-term graft surveillance plan — Annual review for IOP, endothelial cell count, specular microscopy and any signs of late rejection; documented continuity-of-care arrangement.

Frequently asked questions

Methodology and sources

This page is built from foundational corneal surgery literature, UK eye-banking and regulatory standards, registry-level outcome data and the practical experience of UK CQC-registered private corneal services. Prices reflect typical UK 2026 self-pay rates at London corneal centres at the time of publication.

• Anwar M, Teichmann KD. Big-bubble technique to bare Descemet’s membrane in anterior lamellar keratoplasty. British Journal of Ophthalmology 2002.
• Reinhart WJ et al. Deep anterior lamellar keratoplasty as an alternative to penetrating keratoplasty — AAO Ophthalmic Technology Assessment.
• Cochrane systematic review of DALK versus PK in keratoconus.
• NHS Blood and Transplant Tissue and Eye Services standards for donor cornea provision in the UK.
• Royal College of Ophthalmologists clinical guideline on keratoplasty.
• EuCornea (European Society of Cornea and Ocular Surface Disease Specialists) practice guidance.
• American Academy of Ophthalmology Preferred Practice Pattern: Corneal Ectasia.
• British Standards Institute BS EN ISO 17665 and tissue-banking standards for eye banking.
• Wollensak G et al. Riboflavin-UVA corneal cross-linking for keratoconus — foundational CXL evidence.
• Sarnicola E et al. Cross-comparative series on big-bubble and viscoelastic-assisted DALK variants.
• UK Transplant Registry corneal graft survival data.
• Care Quality Commission inspection framework for ophthalmic day-case providers.
• Macular and Corneal Society of the UK patient outcome surveys.

This page is editorial and educational. It is not personalised medical advice. Suitability for DALK transplant, the choice of big-bubble or manual technique, the use of femtosecond laser assistance, the decision to convert intraoperatively to PK and the postoperative drop and suture-care regime are individual decisions made between you and a GMC-registered consultant corneal surgeon following a full clinical assessment including Pentacam topography and specular microscopy. Prices are typical UK 2026 ranges at CQC-registered London centres and may vary.

Book your London DALK consultation

If you have advanced keratoconus, post-hydrops scarring, post-infective stromal opacity or another anterior stromal disease that is no longer adequately corrected by contact lenses, DALK offers a durable visual rehabilitation with materially better long-term graft survival than full-thickness PK. Our consultants are GMC-registered corneal surgeons with completed corneal fellowships, documented DALK case volumes and substantive NHS corneal posts. Call us or use the appointment form to arrange a consultation including Pentacam topography, specular microscopy and a candid discussion of the surgical pathway.

Related reading: Private corneal cross-linking (CXL) · Private intracorneal ring segments · Private CAIRS ring segments · Private penetrating keratoplasty · Keratoconus condition guide